Double-blind trial of mazindol in overweight patients.
A 12-week double-blind trial involving 50 patients from a suburban general practice showed a highly significant loss of weight in the group taking 2 mg of mazindol (Sanorex) per day.
D000328:Adult; D002986:Clinical Trials as Topic; D005194:Family Practice; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008454:Mazindol / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*; D010919:Placebos
D007211:Indoles; D010919:Placebos; D008454:Mazindol